Market revenue in 2024 | USD 1,738.7 million |
Market revenue in 2030 | USD 2,400.3 million |
Growth rate | 5.5% (CAGR from 2025 to 2030) |
Largest segment | Other types |
Fastest growing segment | Other Types |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablet, Liquid, Other Types |
Key market players worldwide | GlaxoSmithKline, Bayer AG, Boehringer Ingelheim, Dr. Reddy’s Laboratories, Sanofi SA, Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Procter & Gamble Co |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antacids market will help companies and investors design strategic landscapes.
Other types was the largest segment with a revenue share of 51.69% in 2024. Horizon Databook has segmented the Asia Pacific antacids market based on tablet, liquid, other types covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific antacids market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific antacids market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account